Anti-angiogenic potential of scopoletin is associated with the inhibition of ERK1/2 activation

Drug Development Research

Volumn 70, Issue 3, 2009, Pages 214-219

  Pan, Rong ^a   Dai, Yue ^a,b   Yang, Jian ^a   Li, Ying ^a   Yao, Xiujuan ^a   Xia, Yufeng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial cell; ERK1 2; Scopoletin

Indexed keywords

COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SCOPOLETIN; STRESS ACTIVATED PROTEIN KINASE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL;

EID: 66249111852     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20297     Document Type: Article

References (22)

1. Adams M, Efferth T, Bauer R. 2006. Activity-guided isolation of scopoletin and isoscopoletin, the inhibitory active principles towards CCRF-CEM leukaemia cells and multi-drug resistant CEM/ADR5000 cells, from Artemisia argyi. Planta Med 72:862-864. (Pubitemid 44204656)
2. Bohlmann F, Jakupovic J. 1979. 8-Oxo-a-Selinen und neue scopoletin-derivate aus Conyza-arten. Phytochemistry 18:1367-1370.
3. Cao Y. 2001. Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 33:357-369. (Pubitemid 32324004)
4. Cao Y, Cao R, Brå kenhielm E. 2002. Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem 13:380-390.
5. Cassady JM, Ojima N, Chang C, McLaughlin HL. 1979. An investigation of the antitumor activity of Micromelum integerrimum (Rutaceae). J Nat Prod 42:274-278.
6. Ding Z, Dai Y, Wang Z. 2005. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity. Planta Med 71:183-185. (Pubitemid 40363565)
7. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:127-131.
8. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267: 10931-10934.
9. Hou Y, Yang J, Zhao G, Yuan Y. 2004. Ferulic acid inhibits endothelial cell proliferation through NO down-regulating ERK1/2 pathway. J Cell Biol 93:1203-1209. (Pubitemid 44264133)
10. Huang C, Jacobson K, Schaller MD. 2004. MAP kinases and cell migration. J Cell Sci 117:4619-4628. (Pubitemid 39433429)
11. Kang SY, Sung SH, Park JH, Kim YC. 1998. Hepatoprotective activity of scopoletin, a constituent of Solanum lyratum. Arch Pharm Res 21:718-722. (Pubitemid 128668404)
12. Komorowski J, Jerczyńska H, Siejka A, Barań ska P, Ławnicka H, Pawłowska Z, Stepień H. 2006. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells. Life Sci 78:2258-2263.
13. Lee S, Sivakumar K, Shin WS, Xie F, Wang Q. 2006. Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg Med Chem Lett 16:4596-4599. (Pubitemid 44094066)
14. Mavria G, Vercoulen Y, Yeo M, Paterson H, Karasarides M, Marais R, Bird D, Marshall CJ. 2006. ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 9:33-44. (Pubitemid 43069509)
15. Meadows KN, Bryant P, Pumiglia K. 2001. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276:49289-49298. (Pubitemid 37370640)
16. Mickuviene I, Kirveliene V, Juodka B. 2004. Experimental survey of non-clonogenic viability assays for adherent cells in vitro. Toxicol In Vitro 18:639-648. (Pubitemid 38900872)
17. Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ. 2002. Preliminary structure antiangiogenic activity relationships of 4-senecioyloxymethyl-6,7- dimethoxycoumarin. Bioorg Med Chem Lett 12:2345-2348.
18. Oak JH, Nakagawa K, Oikawa S, Mivazawa T. 2003. Amadoriglycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett 555:419-423. (Pubitemid 37486066)
19. Risau W. 1995. Differentiation of endothelium. FASEB J 9: 926-933.
20. Shaw CY, Chen CH, Hsu CC, Chen CC, Tsai YC. 2003. Antioxidant properties of scopoletin isolated from Sinomonium acutum. Phytother Res 17:823-825. (Pubitemid 37012271)
21. Wu LW, Chiang YM, Chuang HC, Wang SY, Yang GW, Chen YH, Lai LY, Shyur LF. 2004. Polyacetylenes function as antiangiogenic agents. Pharm Res 21:2112-2119.
22. Zhou Q, Heinke J, Vargas A, Winnik S, Krauss T, Bode C, Patterson C, Moser M. 2007. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res 76:390-399. (Pubitemid 350007461)